Use of EBUS TBNA for Cell Culture as an Aid to Diagnose Lung Cancer and Lymphoma
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Non-Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
A Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)
- Status
- COMPLETED
- Phase
- PHASE1
Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02)
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study of Duvelisib and Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Indolent or Aggressive Non-Hodgkin Lymphoma, Who Have Not Previously Received a Bcl-2 or PI3K Inhibitor
- Status
- WITHDRAWN
- Phase
- PHASE1
Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)
- Status
- TERMINATED
- Phase
- PHASE2
Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Entospletinib (ENTO [GS-9973]) Combined With Vincristine (VCR) in Adult Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE3
Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency
- Status
- COMPLETED
- Phase
- NA
Study of a Novel BET Inhibitor FT-1101 in Patients With Relapsed or Refractory Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1, Dose-Escalation Study of IGN002 in NHL Subjects
- Status
- TERMINATED
- Phase
- PHASE1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Diagnostic Qualities of the Positron Emission Tomography Coupled to the Scanner (PET / CT) in the Assessment of Response to Non-Hodgkin's Lymphoma Therapy in Children and Adolescents
- Status
- COMPLETED
- Phase
- NA
Study of ADCT-301 in Patients With Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive Therapies
- Status
- COMPLETED
- Phase
- NA